https://www.selleckchem.com/pr....oducts/oxythiamine-c
particularly in terms of outpatient (OP) visits. Although effective disease-modifying agent (i.e. mTOR inhibitor) is available, it was not widely used yet in Hong Kong despite the fact that Government approved and supported its use recently. Further research on quality of life and setting up a comprehensive patient registry are necessary for more accurate assessment of cost and benefit. Prevalence of local TSC patients is within the range of that reported in the literature. Local TSC patients have fair long te
Like
Comment
Share
